Fundz

Fundz Deep Dive

Everything you need to win Markus Thor — in one platform.

Who to reach, what to say, and why now on Markus Thor — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Markus Thor — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Qure Tech Bio Appoints Markus Thor As Chief Executive Officer, Replacing Helén Fält

PRIVATESep 03, 2024•almost 2 years ago

Position

Chief Executive Officer

Company

QureTech Bio

Markus Thor
UmeåBiotechnologyHealth CarePharmaceutical

Description

QureTech Bio has appointed Markus Thor as the new Chief Executive Officer to succeed Helén Fält, who will start a new position as Commercial Manager at Apotek Produktion & Laboratorier (APL) in Umeå. Markus Thor brings 30 years of experience in the private and public pharmaceutical industry and biotech. Lennart Hansson, Chairman of the Board of QureTech Bio, expressed confidence in Markus Thor's vision, expertise, and leadership skills to lead the company to the next level of growth and success

Company Information

Company

QureTech Bio

Location

Umeå, Vasterbottens Lan, Sweden

About

QureTech Bio is a pharmaceutical development company with a focus on developing new solutions to combat disease-causing bacteria and contribute to combating antimicrobial resistance (AMR). The company's lead program is focused on developing a new class of antibiotics effective against multidrug-resistant Gram-positive bacteria. QureTech Bio is located in Umeå, one of Sweden's prominent life science clusters.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for QureTech Bio's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.